drugset
drugset / Trial / NCT07394036

Effect of Ipratropium Bromide on EILO

NCT07394036 ↗

Phase 2 Not yet recruiting 50 enrolled Cook Children's Health Care System
RandomizedCrossoverQuadruple-blindTreatment

Summary

The investigators propose a study that compares breathlessness and airway obstruction during intense exercise in 34 children and adolescents with Exercise-Induced Laryngeal Obstruction after breathing in ipratropium bromide or placebo. It is hypothesized that breathlessness and airway obstruction will be lower following breathing in ipratropium bromide compared with placebo.

Timeline

Start
2026-06-01
Primary completion
2029-12-31
Completion
2029-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 500 ug Inhaled

Indications

No indication recorded.